Quarter 2026/Q2
| Line item | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 |
|---|---|---|---|---|---|
| Net cash flow from continuing operations | $2.14B | -$1.34B | -$1.89B | -$697.37M | -$131.32M |
| Net Other Investing Changes | -$250.11M | $13.88M | -$235.75M | $6.88M | -$89.14M |
| Financing Cash Flow | -$1.76B | $1.40B | $1.64B | $404.07M | $239.83M |
| Net Cash Flow from Continuing Financing Activities | -$1.76B | $1.40B | $1.64B | $404.07M | $239.83M |
| Net Issuance Payments Of Debt | $5.16M | $94.23M | -$2.80M | $648.65M | -$9.08M |
| Net Common Stock Issuance | $0.00 | -$50.01M | $0.00 | -$4.74M | $0.00 |
| Cash Dividends Paid | -$15.88M | -$15.60M | -$15.93M | -$15.81M | -$15.81M |
| Proceeds from Stock Option Exercised | $723,000.00 | $3.71M | $2.43M | $4.44M | $513,000.00 |
| Net Other Financing Charges | -$1.75B | $1.37B | $1.66B | -$228.48M | $264.20M |
| Ending Cash Balance | $214.27M | $219.51M | $301.68M | $621.92M | $162.19M |
| Net Change in Cash | -$5.24M | -$82.17M | -$320.24M | $459.74M | -$48.91M |
| Beginning Cash Balance | $219.51M | $301.68M | $621.92M | $162.19M | $211.09M |
| Free Cash Flow | $2.13B | -$1.37B | -$1.91B | -$707.65M | -$141.77M |
| Net Investment Purchase and Sale | -$135.62M | -$137.73M | -$262.97M | $589.38M | -$57.83M |
| Net Intangibles Purchase and Sale | $12.80M | -$2.51M | $448.17M | $167.06M | $0.00 |
| Net Income from Continuing Operations | $21.73M | $82.32M | $106.83M | $181.50M | $136.46M |
| Gain/Loss from Continuing Operations | $187.35M | $209.60M | $41.74M | -$97.33M | $109.06M |
| Other Non-Cash Items | $1.83B | -$1.37B | -$2.05B | -$834.36M | -$392.06M |
| Change in Working Capital | $55.15M | -$301.17M | -$37.30M | $11.89M | -$18.57M |
| -Change in Receivables | -$5.49M | -$4.10M | $19.36M | -$12.36M | -$3.67M |
| -Change in Prepaid Assets | -$45.24M | -$97.07M | -$259.59M | -$28.30M | $10.68M |
| -Change in Payables and Accrued Expense | -$58.48M | -$180.47M | $218.01M | $119.66M | -$39.64M |
| Operating Cash Flow | $2.14B | -$1.34B | -$1.89B | -$697.37M | -$131.32M |
| -Change in Other Current Liabilities | -$4.12M | -$3.94M | -$4.47M | -$4.28M | -$4.93M |
| Net Cash Flow from Continuing Investing Activities | -$389.09M | -$144.53M | -$73.52M | $753.04M | -$157.42M |
| Capital Expenditure | -$12.78M | -$15.93M | -$14.80M | -$8.20M | -$9.15M |
| Net PPE Purchase and Sale | -$3.38M | -$2.25M | -$8.17M | -$2.08M | -$1.31M |
| Net cash flow from investing | -$389.09M | -$144.53M | -$73.52M | $753.04M | -$157.42M |
| -Change in Other Current Assets | $168.48M | -$15.61M | -$10.61M | -$62.83M | $19.00M |
| Depreciation & Depletion & Amortization | $18.83M | $17.74M | $17.22M | $16.48M | $18.36M |
No comments yet — be the first to weigh in on PFSI.